SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-06-003445
Filing Date
2006-05-12
Accepted
2006-05-12 16:05:22
Documents
6
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b60724ipe10vq.htm 10-Q 241711
2 EX-10.1 EMPLOYMENT AGREEMENT DATED, APRIL 13, 2006 b60724ipexv10w1.txt EX-10.1 45241
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b60724ipexv31w1.htm EX-31.1 6182
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b60724ipexv31w2.htm EX-31.2 6205
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO b60724ipexv32w1.htm EX-32.1 3194
6 EX-32.2 SECTION 906 CERTIFICATION OF CFO b60724ipexv32w2.htm EX-32.2 3220
  Complete submission text file 0000950135-06-003445.txt   307245
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 06834912
SIC: 2836 Biological Products, (No Diagnostic Substances)